Yoichi Kase

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 5

Top Topics

Diffuse Large B Cell Lymphoma

Acute Lymphoblastic Leukemia

Top Venues

Journal of anesthesia

Journal of gynecologic oncology

The Journal of international medical research

This page only lists publications with an associated author ORCID identifier.

Publications

Yu Yamamoto, Shohei Kimura, Hideki Kuniyoshi, Takanori Hiroe, Takako Terui, Yoichi Kase
Novice residents' endotracheal intubation skill retention on a simulated mannequin after rotating at an anaesthesiology department: a randomized controlled study. The Journal of international medical research 51 (10) (2023)
Hideki Kuniyoshi, Yu Yamamoto, Shohei Kimura, Takanori Hiroe, Takako Terui, Yoichi Kase
Comparison of the analgesic effects continuous epidural anesthesia and continuous rectus sheath block in patients undergoing gynecological cancer surgery: a non-inferiority randomized control trial. Journal of anesthesia 35 (5) (2021)
Kazuhiro Takehara, Takashi Matsumoto, Junzo Hamanishi, Kosei Hasegawa, Motoki Matsuura, Kiyonori Miura, Shoji Nagao, Hidekatsu Nakai, Naotake Tanaka, Hideki Tokunaga, Kimio Ushijma, Hidemichi Watari, Yoshihito Yokoyama, Yoichi Kase, Shuuji Sumino, Ajit Suri, Hiroaki Itamochi, Nobuhiro Takeshima
Phase 2 single-arm study on the safety of maintenance niraparib in Japanese patients with platinum-sensitive relapsed ovarian cancer. Journal of gynecologic oncology 32 (2) (2021)
Yoichi Kase, Hideki Kuniyoshi, Takako Terui
Reply to the letter titled "Difficulty in evaluating the effect of CEA or CRSB". Journal of anesthesia (2021)
Aikou Okamoto, Asumi Okumura, Toshiaki Nakamura, Satoshi Yanagida, Junzo Hamanishi, Kenichi Harano, Kosei Hasegawa, Takeshi Hirasawa, Kensuke Hori, Shinichi Komiyama, Motoki Matsuura, Hidekatsu Nakai, Hiroko Nakamura, Jun Sakata, Tsutomu Tabata, Kazuhiro Takehara, Munetaka Takekuma, Yoshihito Yokoyama, Yoichi Kase, Shuuji Sumino, Junpei Soeda, Ajit Suri, Daisuke Aoki, Toru Sugiyama
Phase 2 single-arm study on the efficacy and safety of niraparib in Japanese patients with heavily pretreated, homologous recombination-deficient ovarian cancer. Journal of gynecologic oncology 32 (2) (2020)